Cyanotech Corporation (CYAN) Financial Statements (2024 and earlier)

Company Profile

Business Address 73-4460 QUEEN KAAHUMANU HWY
KAILUA KONA, HI 96740
State of Incorp. NV
Fiscal Year End March 31
Industry (SIC) 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
MRQ
3/31/2023
3/31/2022
3/31/2021
3/31/2020
3/31/2019
3/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments9742,5893,7672,4178401,329
Cash and cash equivalents9742,5893,7672,4178401,329
Receivables1,3313,6642,4362,1541,9822,664
Inventory, net of allowances, customer advances and progress billings10,7079,4668,4159,65311,2749,034
Inventory10,7079,4668,4159,65311,2749,034
Other undisclosed current assets484545488504496590
Total current assets:13,49616,26415,10614,72814,59213,617
Noncurrent Assets
Operating lease, right-of-use asset4,7763,7873,5173,834
Property, plant and equipment11,36611,88512,13613,04214,75215,734
Restricted cash and investments      65
Other noncurrent assets90109120183282291
Total noncurrent assets:16,23215,78115,77317,05915,03416,090
TOTAL ASSETS:29,72832,04530,87931,78729,62629,707
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,1224,8653,1312,9865,9144,419
Employee-related liabilities1,091    
Accounts payable1,0212,3622,2872,1374,9223,527
Accrued liabilities1,1011,412844849992892
Deferred revenue89164124327
Debt5,409 2,2102,727948655
Contract with customer, liability626
Other undisclosed current liabilities483(208)3433192,000633
Total current liabilities:8,1034,8215,8086,3599,4885,707
Noncurrent Liabilities
Long-term debt and lease obligation, including:1,0007,7227,9989,5285,3726,023
Long-term debt, excluding current maturities1,0004,3364,8236,00957103
Other undisclosed long-term debt and lease obligation     5,3155,920
Liabilities, other than long-term debt4,278153254  
Other liabilities 3153254  
Operating lease, liability4,2753,3863,1753,519
Other undisclosed noncurrent liabilities     (143)(130)
Total noncurrent liabilities:5,2787,7378,0309,5825,2295,893
Total liabilities:13,38112,55813,83815,94114,71711,600
Equity
Equity, attributable to parent16,34719,48717,04115,84614,90918,107
Common stock125124122120117115
Additional paid in capital33,85633,55733,26732,99432,44732,051
Accumulated deficit(17,634)(14,194)(16,348)(17,268)(17,655)(14,059)
Total equity:16,34719,48717,04115,84614,90918,107
TOTAL LIABILITIES AND EQUITY:29,72832,04530,87931,78729,62629,707

Income Statement (P&L) ($ in thousands)

12/31/2023
TTM
3/31/2023
3/31/2022
3/31/2021
3/31/2020
3/31/2019
3/31/2018
Revenues23,17835,96832,34531,89930,20234,115
Cost of revenue
(Cost of Goods and Services Sold)
(15,919)(22,402)(21,228)(19,199)(19,736)(20,744)
Gross profit:7,25913,56611,11712,70010,46613,371
Operating expenses(10,179)(10,992)(11,033)(11,647)(13,463)(11,957)
Operating income (loss):(2,920)2,574841,053(2,997)1,414
Nonoperating expense (502)    (499)
Interest and debt expense(502)(392)1,389(657)(71)(72)
Other undisclosed loss from continuing operations before equity method investments, income taxes      
Income (loss) from continuing operations before equity method investments, income taxes:(3,924)2,1821,473396(3,068)843
Other undisclosed income (loss) from continuing operations before income taxes502 (550) (511)72
Income (loss) from continuing operations before income taxes:(3,422)2,182923396(3,579)915
Income tax expense (benefit)(18)(28)(3)(9)(17)110
Income (loss) from continuing operations:(3,440)2,154920387(3,596)1,025
Income (loss) before gain (loss) on sale of properties:2,154920387(3,596)1,025
Net income (loss) available to common stockholders, diluted:(3,440)2,154920387(3,596)1,025

Comprehensive Income ($ in thousands)

12/31/2023
TTM
3/31/2023
3/31/2022
3/31/2021
3/31/2020
3/31/2019
3/31/2018
Net income (loss):(3,440)2,154920387(3,596)1,025
Comprehensive income (loss), net of tax, attributable to parent:(3,440)2,154920387(3,596)1,025

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: